hepavac.eu

Hepavac – Cancer Vaccine development for Hepatocellular Carcinoma

Cancer Vaccine development for Hepatocellular Carcinoma. Partner 1 INT (Coordinator). Partner 5 IMM (Vice-Coordinator). Data Safety Monitoring Board. Patient and Clinical Site Representative. Hepavac in the news. Hepatocellular carcinoma is very common in both women and men. The prognosis is poor: only 5-6% of patients survive more than 5. Years after diagnosis. Novel therapies are urgently required. Cancer vaccines also called immunotherapeutic interventions -. HEPAVAC consortium presents at CIMT 2015.

http://www.hepavac.eu/

OVERVIEW OF hepavac.eu

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

19

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR HEPAVAC.EU

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

November

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Friday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.6 out of 5 with 15 reviews

5 star

9

4 star

6

3 star

0

2 star

0

1 star

0

Hey there! Start your review of hepavac.eu

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

6 seconds

FAVICON PREVIEW

16x16
32x32

CONTACTS AT HEPAVAC.EU

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

PAGES IN
THIS WEBSITE

19

SSL

EXTERNAL LINKS

2

SITE IP

84.19.177.128

LOAD TIME

6.012 sec

SCORE

6.2

PAGE TITLE

Hepavac – Cancer Vaccine development for Hepatocellular Carcinoma | hepavac.eu Reviews

<META> DESCRIPTION

Cancer Vaccine development for Hepatocellular Carcinoma. Partner 1 INT (Coordinator). Partner 5 IMM (Vice-Coordinator). Data Safety Monitoring Board. Patient and Clinical Site Representative. Hepavac in the news. Hepatocellular carcinoma is very common in both women and men. The prognosis is poor: only 5-6% of patients survive more than 5. Years after diagnosis. Novel therapies are urgently required. Cancer vaccines also called immunotherapeutic interventions -. HEPAVAC consortium presents at CIMT 2015.

<META> KEYWORDS

1 twitter

2 facebook

3 the consortium

4 partner 2 tue

5 partner 3 unins

6 partner 4 inserm

7 partner 6 cure

8 partner 7 bham

9 partner 8 navar

10 partner 9 uza

CONTENT

Page content here

KEYWORDS ON PAGE

twitter,facebook,the consortium,partner 2 tue,partner 3 unins,partner 4 inserm,partner 6 cure,partner 7 bham,partner 8 navar,partner 9 uza,scientific advisory board,the project,objectives,innovations,strategy,work packages,clinical trial,expected outcomes

SERVER

Apache

POWERED BY

PleskLin

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

Hepavac – Cancer Vaccine development for Hepatocellular Carcinoma | hepavac.eu Reviews

https://hepavac.eu

Cancer Vaccine development for Hepatocellular Carcinoma. Partner 1 INT (Coordinator). Partner 5 IMM (Vice-Coordinator). Data Safety Monitoring Board. Patient and Clinical Site Representative. Hepavac in the news. Hepatocellular carcinoma is very common in both women and men. The prognosis is poor: only 5-6% of patients survive more than 5. Years after diagnosis. Novel therapies are urgently required. Cancer vaccines also called immunotherapeutic interventions -. HEPAVAC consortium presents at CIMT 2015.

INTERNAL PAGES

hepavac.eu

1

Hepavac – Cancer Vaccine development for Hepatocellular Carcinoma – WP 3: Development and GMP manufacturing of an off-the-shelf multi-epitope vaccine

http://www.hepavac.eu/project/work-packages/wp3-development-gmp-manufacturing-shelf-multi-epitope-vaccine

Cancer Vaccine development for Hepatocellular Carcinoma - LOGIN. Partner 1 INT (Coordinator). Partner 5 IMM (Vice-Coordinator). Data Safety Monitoring Board. Patient and Clinical Site Representative. Hepavac in the news. WP 3: Development and GMP manufacturing of an off-the-shelf multi-epitope vaccine. P 3: Development and GMP manufacturing of an off-the-shelf multi-epitope vaccine. Christian Flohr, IMM. 2013-2016 Cancer Vaccine development for Hepatocellular Carcinoma.

2

Hepavac – Cancer Vaccine development for Hepatocellular Carcinoma – Partner 5 – IMM (Vice-Coordinator)

http://www.hepavac.eu/consortium/partner-5-imm-vice-coordinator

Cancer Vaccine development for Hepatocellular Carcinoma - LOGIN. Partner 1 INT (Coordinator). Partner 5 IMM (Vice-Coordinator). Data Safety Monitoring Board. Patient and Clinical Site Representative. Hepavac in the news. Partner 5 IMM (Vice-Coordinator). Artner 5 IMM (Vice-Coordinator). Brief description of the organization. Partner 1 INT (Coordinator). Partner 5 IMM (Vice-Coordinator). 2013-2016 Cancer Vaccine development for Hepatocellular Carcinoma.

3

Hepavac – Cancer Vaccine development for Hepatocellular Carcinoma – Scientific Advisory Board

http://www.hepavac.eu/consortium/scientific-advisory-board

Cancer Vaccine development for Hepatocellular Carcinoma - LOGIN. Partner 1 INT (Coordinator). Partner 5 IMM (Vice-Coordinator). Data Safety Monitoring Board. Patient and Clinical Site Representative. Hepavac in the news. The Scientific Advisory Board (SAB). HEPAVAC is proud to have the following distinguished Scientists as Members of the SAB:. Prof Vincenzo Bronte,. University of Verona, Verona, Italy;. Fond IRCCS Cà Granda Ospedale Maggiore Policlinico and University of Milan, Milan, Italy.

4

Hepavac – Cancer Vaccine development for Hepatocellular Carcinoma – WP 1: Discovery of the hepatocellular carcinoma HLA class I-ligandome

http://www.hepavac.eu/project/work-packages/wp-1-discovery-hepatocellular-carcinoma-hla-class-ligandome

Cancer Vaccine development for Hepatocellular Carcinoma - LOGIN. Partner 1 INT (Coordinator). Partner 5 IMM (Vice-Coordinator). Data Safety Monitoring Board. Patient and Clinical Site Representative. Hepavac in the news. WP 1: Discovery of the hepatocellular carcinoma HLA class I-ligandome. P 1: Discovery of the hepatocellular carcinoma HLA class I-ligandome. Leader: Cecile Gouttefangeas, TUE. 2013-2016 Cancer Vaccine development for Hepatocellular Carcinoma.

5

Hepavac – Cancer Vaccine development for Hepatocellular Carcinoma – WP 2: Discovery of the hepatocellular carcinoma HLA class II-ligandome

http://www.hepavac.eu/project/work-packages/wp-2-discovery-hepatocellular-carcinoma-hla-class-ii-ligandome

Cancer Vaccine development for Hepatocellular Carcinoma - LOGIN. Partner 1 INT (Coordinator). Partner 5 IMM (Vice-Coordinator). Data Safety Monitoring Board. Patient and Clinical Site Representative. Hepavac in the news. WP 2: Discovery of the hepatocellular carcinoma HLA class II-ligandome. P 2: Discovery of the hepatocellular carcinoma HLA class II-ligandome. Leader: Roberto Accolla, INSUB. 2013-2016 Cancer Vaccine development for Hepatocellular Carcinoma.

UPGRADE TO PREMIUM TO VIEW 14 MORE

TOTAL PAGES IN THIS WEBSITE

19

LINKS TO THIS WEBSITE

hepavac2016ump.wordpress.com

News « HEPAVAC-UMP SYMPOSIUM 16 May 2016, HCMC, VIETNAM

https://hepavac2016ump.wordpress.com/news

HEPAVAC-UMP SYMPOSIUM 16 May 2016, HCMC, VIETNAM. Toward advanced treatments for HCC: a platform for an Italy-Vietnam collaboration. HEPAVAC-UMP SYMPOSIUM 16 May 2016, HCMC, VIETNAM. News on liver cancer in Vietnam. Vietnam has about 110,000 new cases of cancer every year and over 73 percent of them die, one of the highest rates in the world, Mai Trong Khoa, deputy director of Hanoi-based Bach Mai Hospital, has warned. The percentage of women with cervical cancer in Ho Chi Minh City is six times higher t...

immatics.mobi

immatics biotechnologies - active against cancer

http://www.immatics.mobi/index.php?page=91&modid2=2013&PHPSESSID=007fd3093eeee3bf4e1dce23f5d45ade

Assigning the return value of new by reference is deprecated in /kunden/395346 72076/webseiten/IMMATICS LIVE/LIMECMS3/oos3/Model.php. Assigning the return value of new by reference is deprecated in /kunden/395346 72076/webseiten/IMMATICS LIVE/LIMECMS3/oos3/Model.php. Assigning the return value of new by reference is deprecated in /kunden/395346 72076/webseiten/IMMATICS LIVE/LIMECMS3/oos3/Controler.php. EU-funded HepaVAC project to develop a vaccine for liver cancer has kicked off. EU-funded IMMOMEC conso...

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL LINKS TO THIS WEBSITE

2

SOCIAL ENGAGEMENT

pages/Hepavac/612720608782495

hepavac

OTHER SITES

hepau.dk

Min hjemmeside er på nuværende tidspunkt under opbygning. Det er dog muligt på nuværende tidspunkt at se et enkelt casemod i casemod sektionen. Det er iøvrigt mit første forsøg på at lave en hjemmeside, så bær over med mig :).

hepaud.com

Home Page | hepaud.com

For Instalment Loans, Payday Loans, Instalment Loans, Personal Loans. 12 month payday loans. 3 Month Payday Loans Are Manageable. Affordability is now key to lending. Why it is better to save than to borrow money. Never take out multiple payday loans. Five Reasons to Use a Direct Payday Lender Not a Broker. This browser cannot play the embedded video file.

hepaus.com

HEP Australia

Vales Point Power Station. Jack Watson Power Station. Widows Creek Fossil Plant. Castle Peak Power Stattion. Welcome to Hansom Environmental Products. Hansom Environmental Products is now marketing it's world leading environmental technology for air pollution control into Europe and Asia. Another important benefit provided by the HEP Agglomerator is its ability to allow the plant to have a greater choice in fuels, which can lower running and maintenance costs or reduce other pollutant concentrations (sul...

hepauum.org

hepauum.org is for sale

Hepauum.org is available for sale! Use our secure system to purchase hepauum.org. What is a premium domain? A premium domain is a domain that is already owned by someone else and is therefore not available for regular registration. How can I buy this domain? How soon will I get the domain? You will receive the domain in your account immediately. Are there any other costs? Or you can transfer to the registrar of your choice any time after 60 days from purchase. What payment methods are offered?

hepavac.com

NOTICE: This domain name expired on 3/23/2018 and is pending renewal or deletion. Welcome to: hepavac.com. This Web page is parked for FREE, courtesy of GoDaddy.com. Would you like to buy this. THE domain at THE price. Visit GoDaddy.com for the best values on. Restrictions apply. See website for details.

hepavac.eu

Hepavac – Cancer Vaccine development for Hepatocellular Carcinoma

Cancer Vaccine development for Hepatocellular Carcinoma. Partner 1 INT (Coordinator). Partner 5 IMM (Vice-Coordinator). Data Safety Monitoring Board. Patient and Clinical Site Representative. Hepavac in the news. Hepatocellular carcinoma is very common in both women and men. The prognosis is poor: only 5-6% of patients survive more than 5. Years after diagnosis. Novel therapies are urgently required. Cancer vaccines also called immunotherapeutic interventions -. HEPAVAC consortium presents at CIMT 2015.

hepavac2016ump.wordpress.com

HEPAVAC-UMP SYMPOSIUM 16 May 2016, HCMC, VIETNAM « "Toward advanced treatments for HCC: a platform for an Italy-Vietnam collaboration"

HEPAVAC-UMP SYMPOSIUM 16 May 2016, HCMC, VIETNAM. Toward advanced treatments for HCC: a platform for an Italy-Vietnam collaboration. HEPAVAC-UMP SYMPOSIUM 16 May 2016, HCMC, VIETNAM. March 16, 2016 4:21 pm. Prof Tran Diep Tuan. Distinguished Professors and Colleagues,. UMP HCMC is truly honored to welcome leading scientists of HEPAVAC, Prof. Luigi Buonaguro and Prof. Francesco Izzo; we also deeply appreciate the support of Italian General Consulate in Ho Chi Minh City. In this meeting, our le...HEPAVAC i...

hepavacbags.com

National Everything Wholesale

hepavacnh.com

HEPA Vacuums IN STOCK & ON SALE In NH - HEPA Vacs in New Hampshire

HEPA VACUUMS IN NH. IN STOCK In New Hampshire. SHIPPED IN 24 HOURS. CALL: 603.432.3277. HEPA VAC 390ASB - Pullman-Holt 1.5 HP HEPA Vacuum. The market leader for HEPA. Vacuums introduces the newest model to its product line-up. Pullman-Holt's 390ASB is a powerful 4-gallon, dry only HEPA. Vacuums, the 390ASB is equipped with a HEPA. Filter that is individually tested and certified, a standard feature on all Pullman-Holt HEPA. Convenient onboard tool and power cord storage. Motor Head: Equipped with 1.3...

hepavacuumanalysis.com

HEPA Vacuum Analysis

The HEPA vacuum analysis indicates the Dustless certified HEPA vacuum meets all requirements for EAP RRP lead safe certification. The HEPA filter is certified to capture 0.3 micron, and the vacuum itself is certified to airtight standards. The HEPA vacuum analysis failed traditional shop vacuums retrofitted with a HEPA filter because the vacuums were not specifically designed for the HEPA filter and could leak air. Types of HEPA Vacuums. Dustless Certified HEPA Wet Dry Vacuum for Jobsite Dust Control.

hepavacuumcleaner.info

HEPA Vacuum Cleaner

Best information and advice for allergy sufferers who want to buy a HEPA cleaner. Why do you need clean air in your home? Ways of purifying air. What is a HEPA filter? Why buy HEPA filter vacuum cleaners? Design of HEPA vacuum cleaners. Alternatives to HEPA filter vacuum cleaners. HEPA vacuum cleaners – a buying guide. Replacement HEPA filters for vacuum cleaners. Caring for your HEPA cleaner. The frightening list includes:. Asthma triggering irritants (pollen for example). Mould, mildew and fungi spores.